| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 53,716 | 50,132 | 64,957 | 67,154 | | Cost of Revenue | 31,776 | 29,348 | 40,317 | 38,241 | | | Gross Profit | 21,940 | 20,784 | 24,640 | 28,913 | | | Operating Expenses | | Research Development | 1,059 | 1,722 | 1,470 | 1,562 | | Selling General and Administrative | 19,557 | 19,248 | 22,205 | 23,576 | | Non Recurring | 513 | 1,013 | 757 | 43,438 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 811 | (1,199) | 208 | (39,663) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 49 | 92 | 207 | 398 | | Earnings Before Interest And Taxes | 860 | (1,107) | 415 | (39,265) | | Interest Expense | 473 | 507 | 813 | 833 | | Income Before Tax | 387 | (1,614) | (398) | (40,098) | | Income Tax Expense | 530 | (398) | 2,464 | 1,309 | | Minority Interest | 32 |
-
|
-
| (33) | | | | Net Income From Continuing Ops | (143) | (1,216) | (2,862) | (41,440) | | | Non-recurring Events | | Discontinued Operations | (5) | (5) | (4) | 23 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (116) | (1,221) | (2,866) | (41,417) | | Preferred Stock And Other Adjustments | (3) | 28 | (25) |
-
| | | Net Income Applicable To Common Shares | ($119) | ($1,193) | ($2,891) | ($41,417) |
|
0.18% Nasdaq 
0.42%
Income Statement
